Catalyst Wire Dossier Catalyst Wire Dossier

AMYVID

Florbetapir F-18 · Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

34 regulatory and trial events tracked for AMYVID, covering 2012-04-06 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol [Phase 2]

See pricing